
GENERIC NAME: paroxetine
BRAND NAME: Paxil, Paxil CR
DRUG CLASS AND MECHANISM:
Paroxetine
is an anti-depressant drug that affects the chemicals that nerves in
the brain use
to communicate with one another. These chemical messengers, called
neurotransmitters, are released by one nerve and taken up by
other nerves.
Neurotransmitters that are released but not taken up by other
nerves are
taken up by the nerves that release them
("reuptake"). Many
experts believe that it is an imbalance among the amounts of
the different
neurotransmitters that are released that causes depression.
Paroxetine
works by inhibiting the reuptake of serotonin by the nerves
that release
it, an action which allows more serotonin to be available to be
taken up
by other nerves. Paroxetine is in a class of drugs called
selective
serotonin reuptake inhibitors (SSRIs), a class that also
contains
fluoxetine (Prozac) and sertraline (Zoloft).
PRESCRIPTION: Yes
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets
(oval): 10 mg (yellow), 20 mg (pink), 30
mg (blue),
and 40 mg (green). Paxil CR, a controlled release form of paroxetine, is available in tablets of 12.5, 25, and 37.5 mg.
STORAGE: Tablets should be kept at room temperature, 15-
30°C
(59-86°F).
PRESCRIBED FOR: Paroxetine
is indicated for the management of depression,
obsessive-compulsive disorders,
panic disorders, and premenstrual dysphoric
disorder.
DOSING: Paroxetine is given as a single daily dose,
usually in
the morning. As with all anti-depressants, the full effect may
not occur
until after a few weeks of therapy. Doses for obsessive-
compulsive
disorders and panic disorders are often higher than those for
depression.
Doses often are adjusted to find the optimal dose. Elderly
patients,
debilitated persons, and patients with certain kidney or liver
diseases
may need lower doses because they metabolize and eliminate
paroxetine more
slowly and, therefore, are prone to develop high blood levels.
DRUG INTERACTIONS: All SSRIs, including
paroxetine, should
not be taken with any of the MAO (mono-amine oxidase)
inhibitor-class of
anti-depressants, for example, isocarboxazid (Marplan),
phenelzine
(Nardil), tranylcypromine (Parnate), and procarbazine
(Matulane). Such
combinations may lead to confusion, high blood pressure,
tremor, and
increased activity. This same type of interaction may also
occur with
selegiline (Eldepryl), fenfluramine (Pondimin), and
dexfenfluramine
(Redux). The anti-ulcer medication, cimetidine (Tagamet) can
increase the
amount of paroxetine in the blood, possibly leading to side
effects.
Paroxetine may increase the risk of bleeding in patients taking
warfarin
(Coumadin) although the mechanism for the interaction is not
known.
Tryptophan can cause headaches, nausea, sweating, and dizziness
when taken
with any SSRI. Phenytoin (Dilantin) and phenobarbital may
decrease the
amount of paroxetine in the body and possibly reducing its
effectiveness.
Paxil CR is approved for continuous or intermittent therapy for premenstrual dysphoric disorder. For intermittent therapy, women take Pacil CR once daily during only the two-week period prior to the onset of their menstrual cycle rather than throughout the month.
PREGNANCY: There are no adequate studies of paroxetine in
pregnant women.
NURSING MOTHERS: It is not known if paroxetine is secreted in breast milk.
SIDE EFFECTS: The most commonly noted side effects
associated with paroxetine are anxiety, sweating, nausea, decreased
appetite, somnolence (sleepiness), dizziness, insomnia, and male sexual disturbances. Dry mouth occurs in about 18% of patients taking
paroxetine.
The withdrawal of treatment with many anti-depressants has been associated with troublesome symptoms. Symptoms have been particularly frequent with anti-depressants, like paroxetine, classified as SSRI's. Specifically, the incidence of symptoms upon withdrawal is between 17% and 30% with paroxetine and fluvoxamine (Luvox), but less than 5% with
other SSRI's.
The most common symptoms of withdrawal have been dizziness,
tiredness, tingling of the extremities, nausea, vivid dreams,
irritability, and poor mood. Other symptoms have included visual disturbances and headaches.
Withdrawal reactions have been reported upon withdrawing SSRI's after an average of 12 to 36 weeks of treatment, but after as few as 5 weeks. Although most authorities have recommended that treatment be discontinued by tapering the SSRI (by gradually reducing the dose), symptoms have occurred despite tapering. Symptoms generally appear within a few days of discontinuing medication and persist for an average of 12 days (up to 21 days). They are relieved within 24 hours by re-administering the medication that was discontinued.
It has been suggested that SSRIs may cause depression to worsen and even lead to
suicide in a small number of patients. These potential side effects are difficult to evaluate in depressed patients because depression can progress with or without treatment, and suicide is itself a consequence of depression. Moreover, the evidence supporting these potential side effects is weak. Therefore, no conclusions can yet be drawn about the relationship between SSRIs and worsening depression and suicide. Until better information is available, patients receiving SSRIs should be monitored for worsening depression and suicidal tendencies.
 |
 |
From the Doctors at MedicineNet.com  |
 |
 |
- citalopram, Celexa - Defines the medication citalopram (Celexa) an antidepressant drug that affects neurotransmitters. Article includes descriptions, uses, drug interactions, and side effects. Source:MedicineNet
- Depression - Learn depression symptoms, treatment, medications, causes, statistics, facts, signs and types (manic [bipolar], major [clinical], postpartum). Source:MedicineNet
- sertraline, Zoloft - Information on the medication sertraline (Zoloft) a drug used to treat depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, and postmenstrual dysphoric disorder. Article includes descriptions, uses, drug interactions, and side effects. Source:MedicineNet
- Read 71 more paroxetine related articles ...
|
| |
 |
Back to Medications IndexLast Editorial Review: 7/1/2004